ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
API referenceFor AI assistants

Trial · NCT03617536

Adverse events200

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

161 to 180 of 200

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousAdenocarcinoma gastricNeoplasms benign, malignant and unspecified (incl cysts and polyps)CR845 0.25 mg Oral Tablet069
seriousAdenocarcinoma gastricNeoplasms benign, malignant and unspecified (incl cysts and polyps)CR845 0.5 mg Oral Tablet066
seriousAdenocarcinoma gastricNeoplasms benign, malignant and unspecified (incl cysts and polyps)CR845 1 mg Oral Tablet167
seriousAdenocarcinoma gastricNeoplasms benign, malignant and unspecified (incl cysts and polyps)Placebo Oral Tablet067
seriousCerebrovascular accidentNervous system disordersCR845 0.25 mg Oral Tablet069
seriousCerebrovascular accidentNervous system disordersCR845 0.5 mg Oral Tablet166
seriousCerebrovascular accidentNervous system disordersCR845 1 mg Oral Tablet067
seriousCerebrovascular accidentNervous system disordersPlacebo Oral Tablet067
seriousMental status changesPsychiatric disordersCR845 0.25 mg Oral Tablet269
seriousMental status changesPsychiatric disordersCR845 0.5 mg Oral Tablet066
seriousMental status changesPsychiatric disordersCR845 1 mg Oral Tablet067
seriousMental status changesPsychiatric disordersPlacebo Oral Tablet067
seriousAcute kidney injuryRenal and urinary disordersCR845 0.25 mg Oral Tablet169
seriousAcute kidney injuryRenal and urinary disordersCR845 0.5 mg Oral Tablet066
seriousAcute kidney injuryRenal and urinary disordersCR845 1 mg Oral Tablet167
seriousAcute kidney injuryRenal and urinary disordersPlacebo Oral Tablet067
seriousCoughRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet069
seriousCoughRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet066
seriousCoughRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet067
seriousCoughRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet167

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03617536/events?page=9

API referenceFor AI assistants